Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering medications: a retrospective registry study on 127,555 patients from the Nationwide OsMed Health-DB Databas (Q40795716)

From Wikidata

Jump to navigation Jump to search

scientific article

Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering medications: a retrospective registry study on 127,555 patients from the Nationwide OsMed Health-DB Database

Language	Label	Description	Also known as
English	Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering medications: a retrospective registry study on 127,555 patients from the Nationwide OsMed Health-DB Databas	scientific article	Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering medications: a retrospective registry study on 127,555 patients from the Nationwide OsMed Health-DB Database

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112890%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering medications: a retrospective registry study on 127,555 patients from the Nationwide OsMed Health-DB Database (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112890%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

type 2 diabetes

0 references

0 references

hospitalization

1 reference

based on heuristic

inferred from title

Gian Paolo Fadini

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112890%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112890%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

2

object named as

Angelo Avogaro

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112890%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

Luca Degli Esposti

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112890%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Pierluigi Russo

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112890%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Stefania Saragoni

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112890%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Stefano Buda

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112890%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Giuseppe Rosano

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112890%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Sergio Pecorelli

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112890%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

OsMed Health-DB Network

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112890%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

publication date

25 June 2015

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112890%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

European Heart Journal

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112890%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

36

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112890%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

36

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112890%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

2454-2462

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26112890%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV301

21 January 2018

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV301

21 January 2018

Cardiovascular actions of incretin-based therapies

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV301

21 January 2018

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV301

21 January 2018

Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV301

21 January 2018

Sitagliptin and the risk of hospitalization for heart failure: a population-based study.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV301

21 January 2018

Sitagliptin use in patients with diabetes and heart failure: a population-based retrospective cohort study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV301

21 January 2018

Dipeptidyl peptidase-4 inhibitors and heart failure: a meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV301

21 January 2018

Dipeptidyl peptidase-4 inhibitors and cardiovascular outcomes: meta-analysis of randomized clinical trials with 55,141 participants

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV301

21 January 2018

Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV301

21 January 2018

Measurements of medication adherence in diabetic patients with poorly controlled HbA(1c)

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV301

21 January 2018

Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV301

21 January 2018

Depressive symptoms and metabolic control in African-Americans with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV301

21 January 2018

Combination therapy with metformin plus sulphonylureas versus metformin plus DPP-4 inhibitors: association with major adverse cardiovascular events and all-cause mortality.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV301

21 January 2018

Pregnancy intentions, maternal behaviors, and infant health: investigating relationships with new measures and propensity score analysis.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV301

21 January 2018

Coronary revascularisation in stable patients after an acute coronary syndrome: a propensity analysis of early invasive versus conservative management in a register-based cohort study.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV301

21 January 2018

A Tutorial and Case Study in Propensity Score Analysis: An Application to Estimating the Effect of In-Hospital Smoking Cessation Counseling on Mortality

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV301

21 January 2018

Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV301

21 January 2018

The path to approval of new drugs for diabetes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV301

21 January 2018

Cardiovascular biology of the incretin system

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV301

21 January 2018

Cardiovascular effects of DPP-4 inhibition: beyond GLP-1.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV301

21 January 2018

Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV301

21 January 2018

Association of antidiabetic medications targeting the glucagon-like peptide 1 pathway and heart failure events in patients with diabetes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV301

21 January 2018

Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV301

21 January 2018

The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV301

21 January 2018

Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV301

21 January 2018

Causal effects in clinical and epidemiological studies via potential outcomes: concepts and analytical approaches

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV301

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40795716&oldid=1903886011"